Search research articles
Contact Us
Filters
Showing results (171-180 of 176) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 176 results.
Nature Medicine
|
October 13, 2015
Excess TGF-β mediates muscle weakness associated with bone metastases in mice
David L Waning, Khalid S Mohammad, Steven Reiken, et al.
Science Translational Medicine
|
September 27, 2023
Targeting ryanodine receptor type 2 to mitigate chemotherapy-induced neurocognitive impairments in mice
Yang Liu, Steven Reiken, Haikel Dridi, et al.
JCI Insight
|
October 28, 2021
Attenuating persistent sodium current-induced atrial myopathy and fibrillation by preventing mitochondrial oxidative stress
Uma Mahesh R Avula, Haikel Dridi, Bi-Xing Chen, et al.
Circulation
|
November 14, 2007
Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function
Stephan E Lehnart, Michael J Ackerman, D Woodrow Benson, et al.
Eclinicalmedicine
|
February 6, 2024
Rycal S48168 (ARM210) for <i>RYR1</i>-related myopathies: a phase one, open-label, dose-escalation trial
Joshua J Todd, Tokunbor A Lawal, Irene C Chrismer, et al.
Acta Neuropathologica
|
April 3, 2020
Intracellular calcium leak as a therapeutic target for RYR1-related myopathies
Alexander Kushnir, Joshua J Todd, Jessica W Witherspoon, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 176) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 176 results.
Nature Medicine
|
October 13, 2015
Excess TGF-β mediates muscle weakness associated with bone metastases in mice
David L Waning, Khalid S Mohammad, Steven Reiken, et al.
Science Translational Medicine
|
September 27, 2023
Targeting ryanodine receptor type 2 to mitigate chemotherapy-induced neurocognitive impairments in mice
Yang Liu, Steven Reiken, Haikel Dridi, et al.
JCI Insight
|
October 28, 2021
Attenuating persistent sodium current-induced atrial myopathy and fibrillation by preventing mitochondrial oxidative stress
Uma Mahesh R Avula, Haikel Dridi, Bi-Xing Chen, et al.
Circulation
|
November 14, 2007
Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function
Stephan E Lehnart, Michael J Ackerman, D Woodrow Benson, et al.
Eclinicalmedicine
|
February 6, 2024
Rycal S48168 (ARM210) for <i>RYR1</i>-related myopathies: a phase one, open-label, dose-escalation trial
Joshua J Todd, Tokunbor A Lawal, Irene C Chrismer, et al.
Acta Neuropathologica
|
April 3, 2020
Intracellular calcium leak as a therapeutic target for RYR1-related myopathies
Alexander Kushnir, Joshua J Todd, Jessica W Witherspoon, et al.
Page
of 18